Immune-Mediated Inflammatory Diseases: Addressing Safety Concerns and Enhancing the Accessibility of Biosimilars. Feiteira CP, Tavares IC, Ribeiro MHL Curr Med Sci. 2026 Jun 09. PMID: 42262644. Abstract CommentRecommendBookmarkWatch
